Reata Pharma Drug Wins First FDA Nod in Ultra-Rare Neuromuscular Disorder

Subscribe To Our Newsletter Careers Information from across the Internet


Reata Pharma Drug Wins First FDA Nod in Ultra-Rare Neuromuscular Disorder Reata Pharma Drug Wins First FDA Nod in Ultra-Rare Neuromuscular Disorder

Skyclarys, a Reata Pharmaceuticals drug, is now approved for treating the rare neuromuscular..
previous post